PFBT
NAGE

Parkside Financial Bank & Trust’s Niagen Bioscience NAGE Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-95
Closed -$605 – 2795
2025
Q4 		$605 Hold
95
– – ﹤0.01% 2525
2025
Q3 		$888 Hold
95
– – ﹤0.01% 2332
2025
Q2 		$1.37K Hold
95
– – ﹤0.01% 2134
2025
Q1 		$656 Buy
+95
New +$597 ﹤0.01% 2239

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Parkside Financial Bank & Trust's NAGE Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 95 shares — an estimated $605 sold.

Parkside Financial Bank & Trust first reported a position in NAGE in Q1 2025 and held it in 4 quarters. The position peaked at $1.37K in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 95 Niagen Bioscience shares in Q1 2026, an estimated $605.
  • Parkside Financial Bank & Trust first reported a position in Niagen Bioscience in Q1 2025 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Niagen Bioscience position peaked at $1.37K in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.